Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease
- PMID: 18723162
- PMCID: PMC2613777
- DOI: 10.1016/j.biopsych.2008.06.020
Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease
Abstract
Background: The utility of combining early markers to predict conversion from mild cognitive impairment (MCI) to Alzheimer's Disease (AD) remains uncertain.
Methods: Included in the study were 148 outpatients with MCI, broadly defined, followed at 6-month intervals. Hypothesized baseline predictors for follow-up conversion to AD (entire sample: 39/148 converters) were cognitive test performance, informant report of functional impairment, apolipoprotein E genotype, olfactory identification deficit, and magnetic resonance imaging (MRI) hippocampal and entorhinal cortex volumes.
Results: In the 3-year follow-up patient sample (33/126 converters), five of eight hypothesized predictors were selected by backward and stepwise logistic regression: Pfeffer Functional Activities Questionnaire (FAQ; informant report of functioning), University of Pennsylvania Smell Identification Test (UPSIT; olfactory identification), Selective Reminding Test (SRT) immediate recall (verbal memory), MRI hippocampal volume, and MRI entorhinal cortex volume. For 10% false positives (90% specificity), this five-predictor combination showed 85.2% sensitivity, combining age and Mini-Mental State Examination (MMSE) showed 39.4% sensitivity; combining age, MMSE, and the three clinical predictors (SRT immediate recall, FAQ, and UPSIT) showed 81.3% sensitivity. Area under ROC curve was greater for the five-predictor combination (.948) than age plus MMSE (.821; p = .0009) and remained high in subsamples with MMSE > or = 27/30 and amnestic MCI.
Conclusions: The five-predictor combination strongly predicted conversion to AD and was markedly superior to combining age and MMSE. Combining the clinically administered measures also led to strong predictive accuracy. If independently replicated, the findings have potential utility for early detection of AD.
Figures


Similar articles
-
Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.Neurology. 2007 Mar 13;68(11):828-36. doi: 10.1212/01.wnl.0000256697.20968.d7. Neurology. 2007. PMID: 17353470
-
Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.Neurology. 2008 Jan 15;70(3):191-9. doi: 10.1212/01.wnl.0000287091.57376.65. Neurology. 2008. PMID: 18195264 Clinical Trial.
-
(99m)Tc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer disease.Am J Geriatr Psychiatry. 2010 Nov;18(11):959-72. doi: 10.1097/JGP.0b013e3181ec8696. Am J Geriatr Psychiatry. 2010. PMID: 20808143 Free PMC article. Clinical Trial.
-
Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.Cochrane Database Syst Rev. 2020 Mar 2;3(3):CD009628. doi: 10.1002/14651858.CD009628.pub2. Cochrane Database Syst Rev. 2020. PMID: 32119112 Free PMC article.
-
Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI).Cochrane Database Syst Rev. 2021 Jul 27;7(7):CD010783. doi: 10.1002/14651858.CD010783.pub3. Cochrane Database Syst Rev. 2021. PMID: 34313331 Free PMC article.
Cited by
-
Alterations in odor hedonics in the 5XFAD Alzheimer's disease mouse model and the influence of sex.Behav Neurosci. 2020 Oct;134(5):407-416. doi: 10.1037/bne0000400. Epub 2020 Aug 6. Behav Neurosci. 2020. PMID: 32757584 Free PMC article.
-
Predicting time-to-conversion for dementia of Alzheimer's type using multi-modal deep survival analysis.Neurobiol Aging. 2023 Jan;121:139-156. doi: 10.1016/j.neurobiolaging.2022.10.005. Epub 2022 Oct 17. Neurobiol Aging. 2023. PMID: 36442416 Free PMC article.
-
A two-year follow-up of cognitive deficits and brain perfusion in mild cognitive impairment and mild Alzheimer's disease.J Alzheimers Dis. 2012;30(1):109-20. doi: 10.3233/JAD-2012-111850. J Alzheimers Dis. 2012. PMID: 22406443 Free PMC article.
-
Psychometric properties of the Brazilian version of Pfeffer's Functional Activities Questionnaire.Front Aging Neurosci. 2014 Sep 25;6:255. doi: 10.3389/fnagi.2014.00255. eCollection 2014. Front Aging Neurosci. 2014. PMID: 25309432 Free PMC article.
-
Olfaction and Aging: A Review of the Current State of Research and Future Directions.Iperception. 2021 Jun 26;12(3):20416695211020331. doi: 10.1177/20416695211020331. eCollection 2021 May-Jun. Iperception. 2021. PMID: 34249327 Free PMC article.
References
-
- Di Carlo A, Lamassa M, Baldereschi M, et al. CIND and MCI in the Italian elderly: frequency, vascular risk factors, progression to dementia. Neurology. 2007;68:1909–1916. - PubMed
-
- Larrieu S, Letenneur L, Orgogozo JM, et al. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology. 2002;59:1594–1599. - PubMed
-
- Petersen RC. Mild cognitive impairment: current research and clinical implications. Semin Neurol. 2007;27:22–31. - PubMed
-
- Lopez OL, Jagust WJ, DeKosky ST, et al. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study. Part 1. Arch Neurol. 2003;60:1385–1389. - PubMed
-
- Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256:240–246. - PubMed
Publication types
MeSH terms
Grants and funding
- R01AG177601/AG/NIA NIH HHS/United States
- P50 AG008702/AG/NIA NIH HHS/United States
- R37 MH035636/MH/NIMH NIH HHS/United States
- P01 AG007232/AG/NIA NIH HHS/United States
- P30 AG08051/AG/NIA NIH HHS/United States
- R01 MH055735/MH/NIMH NIH HHS/United States
- R01 MH035636/MH/NIMH NIH HHS/United States
- P50 AG08702/AG/NIA NIH HHS/United States
- MH35636/MH/NIMH NIH HHS/United States
- R01AG12101/AG/NIA NIH HHS/United States
- P30 AG008051/AG/NIA NIH HHS/United States
- R01 AG017761/AG/NIA NIH HHS/United States
- R01 AG012101/AG/NIA NIH HHS/United States
- MH55735/MH/NIMH NIH HHS/United States
- MH55646/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical